Skip to main content
IFHNOS 2026
Survival outcomes following response-adapted treatment de-escalation in resectable cutaneous squamous cell cancer using pembrolizumab: The De-Squamate study
Verbal Presentation
Presenters
Authors
Authors

A/Prof Rahul Ladwa -